Metastatic Urothelial Carcinoma: Optimizing Care Through Multidisciplinary Teamwork
A urology expert elucidates the collaborative relationship between medical oncology and urology in terms of diagnostic testing, treatment strategies, and patient referrals, while underscoring the crucial role of a multidisciplinary approach in maximizing positive patient outcomes.
EP: 1.Overview a 73-Year-Old Man with Metastatic Urothelial Carcinoma Case
EP: 2.Metastatic Urothelial Carcinoma: Optimizing Care Through Multidisciplinary Teamwork
EP: 3.Examining Molecular Testing in Metastatic Urothelial Cancer: Present and Future
EP: 4.Expert Insights: Biomarker Evaluation and Timing in Management of Patients with mUC
EP: 5.Navigating First-Line Treatment Choices for Metastatic Urothelial Carcinoma
EP: 6.Navigating Later-Line Therapies for Progressive Urothelial Cancer
EP: 7.Managing a Novel Therapeutic Option for mUC Treatment
EP: 8.Challenges, Unmet Needs, and the Future of Advanced Urothelial Carcinoma Management
- Describe the partnership between medical oncology and urology regarding testing, treatment, and referrals.
- What other multidisciplinary team members are involved? Discuss barriers, knowledge gaps, and strategies to improve molecular testing rates.
Ruxolitinib Effective as Second-Line Therapy for Chronic GvHD
July 15th 2021In an interview with Targeted Oncology, Stephanie Lee, MD, MPH, reviewed the updated data from the REACH3 trial along with the efficacy of ruxolitinib in the greater chronic graft versus host disease population.
Read More
Clinical Treatment Act Aims to Improve Survival, Close Racial Health Care Gap
June 28th 2021Across the United States, the health insurance coverage gap continues to impact millions of patients who are largely low-income or are racial minorities. After years of lobbying, Congress has passed the Clinical Treatment Act, which is legislation designed to improve access to health coverage.
Read More
